Study of Vascular Function Before vs After Smoking an E-cigarette as Compared to a Normal Cigarette
- Conditions
- Endothelial Function
- Interventions
- Device: electronic cigarette (e-cigarette)Device: conventional tobacco cigarette
- First Posted Date
- 2022-10-28
- Last Posted Date
- 2022-10-28
- Lead Sponsor
- GWT-TUD GmbH
- Target Recruit Count
- 64
- Registration Number
- NCT05598125
Assessment of Effectiveness and Safety of Luspatercept in Patients Suffering From Lower-risk Myelodysplastic Syndrome.
- First Posted Date
- 2022-01-06
- Last Posted Date
- 2023-10-12
- Lead Sponsor
- GWT-TUD GmbH
- Target Recruit Count
- 70
- Registration Number
- NCT05181592
- Locations
- 🇩🇪
Onkologische Schwerpunktpraxis Heidelberg, Heidelberg, Germany
🇩🇪Gemeinschaftspraxis Hämatologie/Onkologie Magdeburg, Magdeburg, Germany
🇪🇸Hospital General Universitario Gregorio Marañón, Madrid, Spain
Polatuzumab Vedotin Plus Rituximab, Ifosfamide, Carboplatin and Etoposide (Pola-R-ICE) Versus R-ICE Alone in Second Line Treatment of Diffuse Large B-cell Lymphoma (DLBCL)
- Conditions
- Relapsed Diffuse Large B-cell LymphomaRefractory Diffuse Large B-Cell Lymphoma
- Interventions
- First Posted Date
- 2021-04-06
- Last Posted Date
- 2025-02-18
- Lead Sponsor
- GWT-TUD GmbH
- Target Recruit Count
- 306
- Registration Number
- NCT04833114
- Locations
- 🇦🇹
UK Graz Universitätsklinik für Innere Medizin Klinische Abteilung für Hämatologie, Graz, Austria
🇦🇹LKH Hochsteiermark Standort Leoben Abteilung für Innere Medizin Department für Hämato-Onkologie, Leoben, Austria
🇦🇹Ordensklinikum Linz GmbH- Elisabethinen: I. Interne Abteilung Hämato-Onkologie, Linz, Austria
Safety and Tolerance of Epigenetic and Immunomodulating Drugs Combined With Chemotherapeutics in Patients Suffering From Advanced Pancreatic Cancer
- Conditions
- Pancreatic AdenocarcinomaPancreas CancerPancreatic Ductal Adenocarcinoma
- Interventions
- First Posted Date
- 2020-02-06
- Last Posted Date
- 2023-05-01
- Lead Sponsor
- GWT-TUD GmbH
- Target Recruit Count
- 75
- Registration Number
- NCT04257448
- Locations
- 🇩🇪
Universitätsklinikum Essen, Essen, Germany
🇩🇪Universitätsmedizin Göttingen, Göttingen, Germany
🇩🇪Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany
Emicizumab in Acquired Hemophilia A
- First Posted Date
- 2019-12-06
- Last Posted Date
- 2023-01-09
- Lead Sponsor
- GWT-TUD GmbH
- Target Recruit Count
- 47
- Registration Number
- NCT04188639
- Locations
- 🇦🇹
Landeskrankenhaus Salzburg, Universitätsklinikum der PMU, Innere Med. III, Salzburg, Austria
🇩🇪Universitätsklinikum des Saarlandes, Institut für Klinische Hämostaseologie und Transfusionsmedizin, Homburg / Saar, Saarland, Germany
🇩🇪Universitätsklinikum Hamburg-Eppendorf, Med. Klinik II/Gerinnungsambulanz, Hamburg, Germany
ASTRAL- a Clinical Study to Assess the Efficacy and Toxicity of High-dose Chemotherapy
- Conditions
- Lymphoma, B-CellLymphoma, T-CellAggressive Non-hodgkin Lymphoma (aNHL)
- Interventions
- Drug: High dose chemotherapy before allogeneic stem cell transplantation (alloSCT)Procedure: Bone marrow histologyDiagnostic Test: clinical and laboratory parametersDiagnostic Test: PET-CT or CT
- First Posted Date
- 2019-10-10
- Last Posted Date
- 2023-05-24
- Lead Sponsor
- GWT-TUD GmbH
- Target Recruit Count
- 60
- Registration Number
- NCT04121507
- Locations
- 🇩🇪
HELIOS Klinik Berlin-Buch, Klinik für Hämatologie und Stammzelltransplantation, Berlin, Brandenburg, Germany
🇩🇪Universitätsklinikum Carl Gustav Carus Dresden, Medzinische Klinik I, Dresden, Germany
🇩🇪Universitätsklinikum Heidelberg, Medizinische Klinik, Innere Medizin V, Heidelberg, Germany
Comparison of Therapies Before Stem Cell Transplantation in Patients With Higher Risk MDS and Oligoblastic AML
- Conditions
- MDSAML
- Interventions
- First Posted Date
- 2019-08-19
- Last Posted Date
- 2023-10-11
- Lead Sponsor
- GWT-TUD GmbH
- Target Recruit Count
- 150
- Registration Number
- NCT04061239
- Locations
- 🇦🇹
Uniklinikum Salzburg - Landeskrankenhaus, Salzburg, Austria
🇩🇪Universitätsklinikum Augsburg, Augsburg, Germany
🇩🇪Klinikum Frankfurt (Oder) GmbH, Frankfurt, Germany
Evaluating the Efficacy and Safety of Bemcentinib in Patients With Myelodysplastic Syndromes
- Conditions
- Low-risk Myelodysplastic SyndromeHigh-risk Myelodysplastic SyndromeAcute Myeloid Leukemia
- Interventions
- First Posted Date
- 2019-01-31
- Last Posted Date
- 2021-12-21
- Lead Sponsor
- GWT-TUD GmbH
- Target Recruit Count
- 45
- Registration Number
- NCT03824080
- Locations
- 🇳🇱
VU University Medical Center, Amsterdam, Netherlands
🇩🇪Universitätsklinikum Dresden, Dresden, Germany
🇫🇷CHU Hôtel Dieu Service d'Hématologie Clinique, Nantes, Nantes Cedex 1, France
Study in Patients With Chronic Leukemia
- First Posted Date
- 2019-01-17
- Last Posted Date
- 2023-09-14
- Lead Sponsor
- GWT-TUD GmbH
- Target Recruit Count
- 18
- Registration Number
- NCT03807479
- Locations
- 🇩🇪
University Hospital, Halle (Saale), Saxony-Anhalt, Germany
🇩🇪University Hospital RWTH Aachen,Clinic for Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Department IV, Aachen, Germany
🇩🇪Asklepios Clinic St. Georg - Department of Oncology, Section Hematology, Hamburg, Germany
Quality of Life in Patients With Non-adipocyte Soft Tissue Sarcoma Under Palliative Chemotherapy or Pazopanib
- Conditions
- Soft Tissue Sarcoma Adult
- Interventions
- First Posted Date
- 2018-11-08
- Last Posted Date
- 2021-09-22
- Lead Sponsor
- GWT-TUD GmbH
- Target Recruit Count
- 11
- Registration Number
- NCT03735758
- Locations
- 🇩🇪
Vivantes Klinikum Spandau, Berlin, Germany
🇩🇪Uniklinik Frankfurt, Frankfurt, Germany
🇩🇪Universitätsklinikum Mannheim, Mannheim, Germany